Iradimed (IRMD) Total Current Liabilities (2013 - 2026)

Iradimed (IRMD) has reported Total Current Liabilities for 14 consecutive years, with $9.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 3.96% year-over-year to $9.2 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a 3.96% increase from a year earlier, with the FY2025 full-year figure at $10.2 million, up 19.6% from the prior year.
• Total Current Liabilities was $9.2 million for Q2 2026 at Iradimed, down from $12.1 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $16.3 million in Q4 2023 and troughed at $5.6 million in Q3 2022.
• A 5-year average of $8.8 million and a median of $8.3 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 90.88% in 2023 and tumbled 47.87% in 2024, its largest moves.
• Over 5 years, Total Current Liabilities stood at $8.6 million in 2022, then surged by 90.88% to $16.3 million in 2023, then tumbled by 47.87% to $8.5 million in 2024, then climbed by 19.6% to $10.2 million in 2025, then slipped by 9.98% to $9.2 million in 2026.
• The last three Total Current Liabilities figures came in at $9.2 million (Q2 2026), $12.1 million (Q1 2026), and $10.2 million (Q4 2025), per Business Quant data.